Actively Recruiting
An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support
Led by Loyola Marymount University · Updated on 2025-09-11
1410
Participants Needed
1
Research Sites
55 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This randomized controlled trial (RCT) will evaluate the feasibility and efficacy of Pink Cloud, a mobile health application designed to support recovery from substance and alcohol use disorders (SUD/AUD). The app provides access to over 245,000 in-person and virtual 12-Step meetings, along with features such as a sobriety counter, daily planner, and personal inventory tools. In this study, 1,410 participants in various stages of recovery will be randomly assigned to receive either access to the Pink Cloud app or to a control condition. Participants will complete follow-up assessments at 1, 3, and 6 months. Primary outcomes include number of days sober and frequency of drug and alcohol problems. Secondary outcomes include meeting attendance, proportion of sober individuals in one's social network, and engagement in recovery-related activities. The investigators hypothesize that participants in the Pink Cloud group will report more days sober and fewer substance use problems than those in the control group, and that they will also report attending more meetings, having a greater proportion of sober peers, and engaging more frequently in recovery activities.
CONDITIONS
Official Title
An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant is 18 years of age or older
- Participant is willing to attend a 12-Step or peer-to-peer recovery meeting (in person or virtual) within the next week
- Participant owns a personal smartphone with cellular service
- Participant is a permanent resident of the United States
- Participant feels comfortable reading and understanding written English in everyday situations
- Participant has consumed alcohol and/or used drugs (excluding tobacco or prescribed medication) at some point in their life, but not within the past couple of days
- Participant is not currently attending outpatient or residential treatment for substance and/or alcohol use
- Participant does not have a plan to enter substance and/or alcohol treatment in the next 30 days
- Participant has been invited by the research team to either the intervention or control condition and redeemed their subscription code
- Informed consent is provided
You will not qualify if you...
- Participant is younger than 18 years of age
- Participant is unwilling to attend a 12-Step or peer-to-peer recovery meeting (in person or virtual) within the next week
- Participant does not own a personal smartphone with cellular service
- Participant is not a permanent resident of the United States
- Participant does not feel comfortable reading and understanding written English in everyday situations
- Participant has consumed alcohol or used drugs (excluding tobacco or prescribed medication) within the past couple of days
- Participant has never consumed alcohol or used drugs
- Participant is currently attending outpatient or residential treatment for substance and/or alcohol use
- Participant has a plan to enter substance and/or alcohol treatment in the next 30 days
- Participant was not invited by the research team or did not redeem their assigned subscription code
- Informed consent is not provided
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Loyola Marymount
Los Angeles, California, United States, 90045
Actively Recruiting
Research Team
J
Joseph LaBrie, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here